Want to join the conversation?
3Q15 net cash used in financing activities was $1,809MM, and was mainly due to debt repayments of $1,627MM and cash dividends paid to shareholders of $292MM. This was partially offset by $186MM in net proceeds from the exercise of share options and purchases under $AVGO's ESPP, and an excess tax benefit of $102MM.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.